Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers, Novo Nordisk diabetes drugs face FDA review, while Amylin preps for application
Bristol-Myers, Novo Nordisk diabetes drugs face FDA review, while Amylin preps for application
Bristol-Myers, Novo Nordisk diabetes drugs face FDA review, while Amylin preps for application
Submitted by
admin
on March 26, 2009 - 2:46pm
Source:
Yahoo/AP
News Tags:
Bristol-Myers Squibb
Novo Nordisk
FDA
Amylin
Alkermes
saxagliptin
Byetta
Headline:
Bristol-Myers, Novo Nordisk diabetes drugs face FDA review, while Amylin preps for application
Do Not Allow Advertisers to Use My Personal information
